Talisman Mining Ord Shs TLM

Primary Symbol: TLSMF

Metals & Mining Industrial Metals & Minerals

Talisman Mining Limited is an Australia-based mineral development and exploration company. The Company is engaged in the exploration, discovery and development of opportunities in base and precious metals. It has secured tenements in the Cobar/Mineral Hill region in Central New South Wales (NSW) through the grant of its own exploration licenses and through a joint venture agreement. Its projects include Lachlan Base Metal and Copper-Gold Project, Mabel Creek Project and Yarindury Porphyry Copper-Gold Project. Its Lachlan Project encompasses approximately 7,100 square kilometers (km2) land position in the highly prospective Lachlan Fold Belt of central New South Wales. It also has over 1040 km2 of highly prospective tenure in Mabel Creek Project, which is a prospective for iron oxide copper gold (IOCG) deposits and intrusion related rare earth and battery metals mineralization. Yarindury Project is located 30km east of Dubbo in the Macquarie Volcanic Arc of central-western NSW.

OTCPK:TLSMF - Post by User

Talisman Mining Ord Shs

Bullboard Posts

Comment by 13thon Feb 13, 2008 12:00am

895 Views

Post# 14364076

RE: Market Call

"""-----INNEXUS BIOTECHNOLOGY INC ( IXS.V )-----"""size=4>color=RED> MAJOR NEWS----InNexus says study shows DXL625 kills tumour cellssize=4> INNEXUS BIOTECHNOLOGY ( TRADING JUST AT 0.35 CENTS ) ANNOUNCES PRELIMINARY RESULTS OF ANIMAL STUDY COMPARING CANCER KILLING ACTIVITY OF ITS DXL625 (CD20) TREATMENT FOR NON-HODGKIN'S LYMPHOMA WITH LEADING MARKETED PRODUCT UP 200% AND RISING FAST,,HEDGE FUNDS ARE BUYING LARGEsize=4>color=RED> https://stockcharts.com/h-sc/ui?s=ixs.V&p=D&b=5&g=0&id=p95524307080 -PENDING NEWS OF 30 MILLION ROYALTY @ PRICE OF $ 1.01 GANA MAKE THIS STOCK FLY -DXL 625 is IXS's first drug offering that enhances or betters Rituxan a $2.06 Billion a year drug. -The animal testing results show that DXL 625 is more effective than Rituxan (remember a $2 Billion drug). -The CEO has indicated a 2nd drug is in the works and another $30 Million from Royalty will be soon be available to company @ price of $ 1.01 per share Show me another Biotech with this much going for it with such a low market cap. This thing is going to take off.------------- Recommandation *STRONG BUY* --------------size=4> THIS STOCK IS AT THE TOP OF THE PHARMACEUTICAL WORLD - PLACE YOUR BETS BUY LOW BEFORE HEADING TO DA MOOOOOOOOOON

Bullboard Posts

Nextech CEO provides company update on Amazon deal and more